Special clinical interest in Nuclear Medicine - Theranostics
David developed an enduring interest in radiopharmaceutical therapy and oncologic nuclear medicine during his Fellowship at the University of Michigan, Ann Arbor. He joined the GenesisCare team to pursue his interest in Theranostics after serving as Deputy Director of Nuclear Medicine at Royal Brisbane Hospital, and senior staff specialist at Austin Health and Gold Coast University Hospital. Author on 40 peer-reviewed publications, he has participated in Phase I-III clinical trials of diagnostic and therapeutic agents and serves as medical monitor.
David is an adjunct Associate Professor with the University of Queensland School of Clinical Medicine.